The global prostatic artery embolization market is a small but rapidly evolving segment within the broader urology field. Prostatic artery embolization is a minimally invasive treatment option for symptomatic benign prostatic hyperplasia in which small beads or coils are delivered via catheter into the arteries that supply blood to the prostate gland. This results in ischemia or lack of blood flow to parts of the enlarged prostate, causing it to shrink in size and thereby relieving urinary obstruction symptoms. The procedure is performed under local anesthesia on an outpatient basis and offers benefits like faster recovery time and fewer side effects compared to transurethral resection of the prostate. Growing awareness about the benefits of prostatic artery embolization and rising prevalence of benign prostatic hyperplasia, especially in aging male populations, are expected to drive strong demand over the coming years. The Global Prostatic Artery Embolization Market is estimated to be valued at US$ 270.72 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Prostatic Artery Embolization Market Growth are Ingersoll-Rand plc (Nexia), Vivint, Inc., Protection One Alarm Monitoring, Inc., The ADT Corporation, Telus Communications, Frontpoint Security Solutions, AT&T Inc., Johnson Controls, Inc., Comcast Corporation, Charter Communications (TWC), and CenturyLink, Inc..
The global prostatic artery embolization market is driven by the growing prevalence of benign prostatic hyperplasia among aging male populations globally. According to the National Institutes of Health, approximately 70% of men in their 60s and 80% in their 70s and older have symptoms of BPH.
Technological advancements are also supporting the adoption of prostatic artery embolization procedures. Key players are focusing on developing real-time navigation systems, enhanced PTA microcatheters, and personalized embolization protocols to further optimize outcomes and efficiency of prostatic artery embolization.
Market Trends
One of the key trends in the prostatic artery embolization market is the increasing preference for minimally invasive treatments. Prostatic artery embolization is less invasive than transurethral resection of the prostate and offers benefits like quicker recovery. This is increasing its acceptance over more conventional BPH treatments.
Another major trend is the growing adoption in healthcare facilities across major markets. While prostatic artery embolization was initially only available in specialized interventional radiology centers, it is now being adopted in both private and public hospitals. This is expanding access and driving higher volumes.
Market Opportunities
Rising awareness campaigns by medical organizations represent a major market opportunity for prostatic artery embolization. Educating patients and physicians about the advantages of this minimally invasive option can help address unmet needs.
Furthermore, the market remains under-penetrated in developing regions. Infrastructure improvements and skills development initiatives can help introduce prostatic artery embolization in new geographies and capture the large untapped demand.
Get more insights on Prostatic Artery Embolization Market
Also read related article on Prostatic Artery Embolization Market
Comments
0 comment